This study aims to add to the literature to inform future strategies to improve long-term adherence and support patients in reaching their treatment goals
Figure 1: Landscape of GLP-1 coverage in Medicaid for weight loss indication "Recent change" is relative to KFFs August 2024 report
I never was able to get to the weight I needed to be, no matter what I did, no matter how much I trained, she told the outlet
Chia CW, Odetunde JO, Kim W, Carlson OD, Ferrucci L, Egan JM (2014) GIP contributes to islet trihormonal abnormalities in type 2 diabetes
What I found in reviewing the data is that most gastrointestinal side effects peaked during dose escalation and reduced once participants reached their maintenance dose
Participants taking 12mg lost an average of 28.7% body weight, approximately 71 pounds